Clapham Rachel E, Roberts Lara N
King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK.
School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Res Pract Thromb Haemost. 2022 Dec 27;7(1):100030. doi: 10.1016/j.rpth.2022.100030. eCollection 2023 Jan.
Venous thromboembolism (VTE) remains a leading cause of preventable morbidity and mortality associated with hospitalization. Despite evidence that providing appropriate thromboprophylaxis to those at risk of VTE in hospital, recent data suggest that the delivery of thromboprophylaxis remains suboptimal across the globe, with a lack of standardization in approach to VTE prevention. This review considers the role of VTE risk assessment and interventions to improve the implementation of the VTE prevention pathway and highlights the systematic approach to VTE prevention adopted in England and its impact. Finally, the critical areas for further research and the emerging data presented during the 2022 ISTH annual congress in London, UK, are summarized.
静脉血栓栓塞症(VTE)仍然是与住院相关的可预防发病和死亡的主要原因。尽管有证据表明应对医院中VTE风险人群提供适当的血栓预防措施,但最近的数据表明,全球范围内血栓预防措施的实施仍未达到最佳水平,在VTE预防方法上缺乏标准化。本综述探讨了VTE风险评估和干预措施在改善VTE预防途径实施方面的作用,并强调了英国采用的VTE预防系统方法及其影响。最后,总结了2022年在英国伦敦举行的国际血栓与止血学会(ISTH)年会上提出的进一步研究的关键领域和新出现的数据。